Dr. Fairley will be teaching medical microbiology and immunology to first year DO students. Dr. Fairley’s research interests focus on the various aspects of nanoscience and nanotechnology. In particular, she is interested in intracellular trafficking of nanoparticles.
Dr. Fairley’s research interest include nanoscience and nanotechnology, particularly the intracellular trafficking of nanoparticles.
A Simple Microfluidic Platform for Long-Term Analysis and Continuous Dual-Imaging Detection of T-Cell Secreted IFN-γ and IL-2 on Antibody-Based Biochip. Baganizi DR, Leroy L, Laplatine L, Fairley SJ, Heidmann S, Menad S, Livache T, Marche PN, Roupioz Y. Biosensors (Basel). 2015 Dec 4;5(4):750-67. doi: 10.3390/bios5040750.
Chlamydia trachomatis recombinant MOMP encapsulated in PLGA nanoparticles triggers primarily T helper 1 cellular and antibody immune responses in mice: a desirable candidate nanovaccine. Fairley SJ, Singh SR, Yilma AN, Waffo AB, Subbarayan P, Dixit S, Taha MA, Cambridge CD, Dennis VA. Int J Nanomedicine. 2013;8:2085-99. doi: 10.2147/IJN.S44155. Epub 2013 May 30.
Formulation, characterization, and expression of a recombinant MOMP Chlamydia trachomatis DNA vaccine encapsulated in chitosan nanoparticles. Cambridge CD, Singh SR, Waffo AB, Fairley SJ, Dennis VA. Int J Nanomedicine. 2013;8:1759-71. doi: 10.2147/IJN.S42723. Epub 2013 May 10.
The anti-inflammatory cytokine, interleukin-10, inhibits inflammatory mediators in human epithelial cells and mouse macrophages exposed to live and UV-inactivated Chlamydia trachomatis. Yilma AN, Singh SR, Fairley SJ, Taha MA, Dennis VA. Mediators Inflamm. 2012;2012:520174. doi: 10.1155/2012/520174. Epub 2012 Feb 19.
© 2024 Philadelphia College of Osteopathic Medicine